Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Joe Still not paying employees, lawsuit filed
PDF is here: https://easyupload.io/mrwo7i
Page 1 of 7
IN THE UNITED STATES DISTRICT COURT
FOR THE SOUTHERN DISTRICT OF FLORIDA
FORT-LAUDERDALE DIVISION
Marcos Velez, and ) CIVIL ACTION NO.____________________
Nerva Garcia, )
) COMPLAINT
Plaintiffs, )
)
v. )
) JURY TRIAL DEMAND
NuGenerex Diagnostic LLC, )
Generex Biotechnology )
Corporation, and Joseph Moscato, )
)
Defendants. )
COMPLAINT
COMES NOW, the Plaintiffs, Marcos Velez (“Velez”) and Nerva Garcia (“Garcia”)
(collectively “Plaintiffs”), by and through their undersigned counsel, and hereby sue Defendants
NuGenerex Diagnostic, LLC, Generex Biotechnology Corporation and Joseph Moscato
(collectively “Defendants”) for unpaid wages and in support thereof alleges as follows:
PARTIES, JURISDICTION, AND VENUE
1. Plaintiffs bring this action for unpaid wages under the Fair Labor Standards Act, as
amended, 29 U.S.C. § 216(b) (the “FLSA”). Plaintiffs are also seeking reasonable attorneys’
fees and costs.
2. The Court has jurisdiction over Plaintiffs’ claims pursuant to 28 U.S.C. § 1337, 1331 and
the FLSA.
3. Venue is proper pursuant to 28 U.S.C. § 1391(b)(1) and (2) because Defendants transact
business in this District; because Defendants' operations are situated in this District; because
Case 0:19-cv-62625-RS Document 1 Entered on FLSD Docket 10/22/2019 Page 1 of 7
Page 2 of 7
most, if not all, of the operational decisions were made in this District; and because Plaintiffs
worked for Defendants in this District.
4. At all times material, Plaintiff Velez is director of finance and operations for Defendants
and performed related activities for Defendants in, inter alia, Broward County, Florida.
5. At all times material, Plaintiff Garcia was laboratory manager and quality control for
Defendants and performed related activities for Defendants in, inter alia, Broward County,
Florida.
6. Defendant NuGenerex Diagnostic, LLC (“NuGenerex”) is a Florida limited liability
company that operates and conducts business in Broward County, Florida, and is therefore,
within the jurisdiction of the Court.
7. Defendant Generex Biotechnology Corporation (“Generex Bio.”) is a foreign corporation
and the parent company of Defendant NuGenerex. Defendant Generex Bio directs the operations
of Defendant NuGenerex in Broward County, Florida, and is therefore, within the jurisdiction of
the Court.
8. Defendant Joseph Moscato (“Moscato”), is an individual, sui juris, and is an owner and
corporate officer of Defendant Generex Bio. Defendant Moscato acts directly and indirectly in
the interest of Defendant Generex Bio. and Defendant NuGenerex in Broward County and has
the power to direct employees' actions in Broward County, Florida. Defendant Moscato has
management responsibilities, degree of control over Defendant Generex Bio. and Defendant
NuGenerex’s financial affairs and compensation practices, and is in a position to exert
substantial authority over corporate policy relating to employee wages and overtime and whether
to compensate (or not to compensate) employees at Defendant NuGenerex and Defendant
Generex Bio. in accordance with the FLSA, making Defendant Moscato an employer pursuant to
Case 0:19-cv-62625-RS Document 1 Entered on FLSD Docket 10/22/2019 Page 2 of 7
Page 3 of 7
29 USC§ 203(d). Defendant Moscato also has the power to hire and fire Plaintiffs, set Plaintiffs'
compensation and work schedule, and maintains Plaintiffs' employment records.
COVERAGE
9. At all material times relevant to this action, Defendant NuGenerex and Defendant
Generex Bio. are enterprises covered by the FLSA, and as defined by 29 U.S.C. § 203(r) and
203(s).
10. At all material times relevant to this action, Defendant NuGenerex, Defendant Generex
Bio. and Defendant Moscato are employers as defined by 29 USC§ 203(d).
11. Defendants are joint employers under 29 C.F.R. 791.2(b)(3) because the Defendants are
not completely disassociated with respect to the employment of Plaintiffs, and may be deemed to
share control of the employees, directly or indirectly, by reason of the fact that one employer
controls, is controlled by, or is under the common control with the other employers.
12. During all material times, Defendants employed two or more people engaged in
commerce, handling or otherwise working on medical materials which have been moved in or
produced for commerce outside the state of Florida.
13. During all material times, Defendant NuGenerex and Defendant Generex Bio. had an
annual gross volume of sales made or business done of not less than $500,000 (exclusive of
excise taxes at the retail level which are separately stated).
14. During all times material, Defendants accepted payments from businesses based on credit
cards issued by out-of-state banks.
15. During all times material, Defendants routinely ordered materials or supplies from out of
state.
Case 0:19-cv-62625-RS Document 1 Entered on FLSD Docket 10/22/2019 Page 3 of 7
Page 4 of 7
16. Plaintiffs were individually engaged in commerce during their employment with
Defendants, by working with medical supplies and equipment from out-of-state.
17. Plaintiffs regularly engaged in the process of selling medical supplies and equipment to
out-of-state businesses for Defendants.
18. Defendants used U.S. Mail to send and receive correspondence to and from other states.
Factual Background
19. On or about January 2006, Plaintiff Velez began employment with Hema Diagnostics.
20. On or about April 2, 2012, Plaintiff Garcia began employment with Hema Diagnostics.
21. Hema Diagnostics was then purchased by Defendant Generex Bio. at the end of 2018.
Defendant Generex Bio. then changed the name of Hema Diagnostics to Defendant NuGenerex.
22. Plaintiff Velez has not been paid wages for work done for Defendants since January 1,
2019.
23. Plaintiff Garcia has not been paid wages for work done for Defendants since January 1,
2019.
COUNT I – UNPAID WAGES
(Fair Labor Standards Act, 29 U .S.C. § 201, et seq)
24. Plaintiff Velez reincorporates and readopts all allegations contained within Paragraphs 1-
19, 21-22 above.
25. At all times relevant to this action, Plaintiff Velez is an employee of Defendants within
the meaning of the FLSA 29 U.S.C. §203(e).
26. At all times relevant to this action, Defendants are Plaintiff Velez’s employer within the
meaning of the FLSA 29 U.S.C. §203(d).
Case 0:19-cv-62625-RS Document 1 Entered on FLSD Docket 10/22/2019 Page 4 of 7
Page 5 of 7
27. At all times relevant, Plaintiff Velez is employed by Defendants within the meaning of
the FLSA 29 U.S.C. §203(g).
28. At all times material, Plaintiff Velez acted at the direction and control of Defendants as to
where he worked, and the hours he worked.
29. Plaintiff Velez was paid a salary of $93,969 in 2018 for working Monday to Friday.
30. Plaintiff Velez has not been paid for work done for Defendants since January 1, 2019 to
the present.
31. Plaintiff Velez continues to work Monday to Friday throughout 2019, yet has not been
paid by Defendants.
32. As a result of Defendants’ intentional, willful and unlawful acts by refusing to pay
Plaintiff Velez owed wages, Plaintiff Velez has suffered damages plus incurring reasonable
attorneys' fees and costs.
33. Defendants knew or showed reckless disregard for whether the FLSA prohibited its
conduct.
34. As a result of Defendants’ willful violation of the Fair Labor Standards Act, Plaintiff
Velez is entitled to unpaid wages and liquidated damages.
WHEREFORE, Plaintiff Velez demands judgment in his favor and against Defendants,
jointly and severally, as follows:
a) Award to Plaintiff Velez of all wages owed under the FLSA;
b) Award to Plaintiff Velez liquidated damages equal to the payment of all wages owed
under the FLSA;
c) Award to Plaintiff Velez of reasonable attorneys' fees and costs; and
d) Award such other and further relief as this Court may deem just and proper.
Case 0:19-cv-62625-RS Document 1 Entered on FLSD Docket 10/22/2019 Page 5 of 7
Page 6 of 7
COUNT II – UNPAID WAGES
(Fair Labor Standards Act, 29 U .S.C. § 201, et seq)
35. Plaintiff Garcia reincorporates and readopts all allegations contained within Paragraphs
1-18, 20, 21, and 23 above.
36. At all times relevant to this action, Plaintiff Garcia was an employee of Defendants
within the meaning of the FLSA 29 U.S.C. §203(e).
37. At all times relevant to this action, Defendants were Plaintiff Garcia’s employer within
the meaning of the FLSA 29 U.S.C. §203(d).
38. At all times relevant, Plaintiff Garcia was employed by Defendants within the meaning of
the FLSA 29 U.S.C. §203(g).
39. At all times material, Plaintiff Garcia acted at the direction and control of Defendants as
to where to work, and the hours she worked.
40. Plaintiff Garcia’s hourly pay rate was $25/hour and she worked Monday to Friday for
Defendants.
41. Plaintiff Garcia has not been paid for work done for Defendants since January 1, 2019.
42. As a result of Defendants’ intentional, willful and unlawful acts by refusing to pay
Plaintiff Garcia owed wages, Plaintiff Garcia has suffered damages plus incurring reasonable
attorneys' fees and costs.
43. Defendants knew or showed reckless disregard for whether the FLSA prohibited its
conduct.
44. As a result of Defendants’ willful violation of the Fair Labor Standards Act, Plaintiff
Garcia is entitled to unpaid wages and liquidated damages.
Case 0:19-cv-62625-RS Document 1 Entered on FLSD Docket 10/22/2019 Page 6 of 7
Page 7 of 7
WHEREFORE, Plaintiff Garcia demands judgment in her favor and against Defendants,
jointly and severally, as follows:
a) Award to Plaintiff Garcia of all wages owed under the FLSA;
b) Award to Plaintiff Garcia liquidated damages equal to the payment of all wages owed
under the FLSA;
c) Award to Plaintiff Garcia of reasonable attorneys' fees and costs; and
d) Award such other and further relief as this Court may deem just and proper.
Demand for Jury Trial
Plaintiffs demand a trial by jury on all issues so triable.
Plaintiffs, Marcos Velez and Nerva Garcia, pray that this Court enter judgment in their
favor against Defendants NuGenerex Diagnostic, LLC, Generex Biotechnology Corporation and
Joseph Moscato, and award monetary damages and liquidated damages, reasonable attorneys'
fees and costs and any other relief this Court deems appropriate.
DATED this Tuesday, October 22, 2019.
Respectfully submitted,
/s Nnamdi Jackson
Nnamdi S. Jackson, Esq.
Fla. Bar No. 99804
THE LAW OFFICE OF NNAMDI S. JACKSON, P.A.
2645 Executive Park Drive,
Suite 340
Weston, Florida 33331
Tel: (954) 670-1267
Fax: (954) 385-9814
njackson@nsjlawoffice.com
Case 0:19-cv-62625-RS Document 1 Entered on FLSD Docket 10/22/2019 Page 7 of 7
Case 0:19-cv-62625-RS Document 1-1 Entered on FLSD Docket 10/22/2019 Page 1 of 1
AO 440 (Rev. 06/12) Summons in a Civil Action
UNITED STATES DISTRICT COURT
for the
__________ District of __________
)
)
)
)
)
)
)
)
)
)
)
)
Plaintiff(s)
v. Civil Action No.
Defendant(s)
SUMMONS IN A CIVIL ACTION
To: (Defendant’s name and address)
A lawsuit has been filed against you.
Within 21 days after service of this summons on you (not counting the day you received it) — or 60 days if you
are the United States or a United States agency, or an officer or employee of the United States described in Fed. R. Civ.
P. 12 (a)(2) or (3) — you must serve on the plaintiff an answer to the attached complaint or a motion under Rule 12 of
the Federal Rules of Civil Procedure. The answer or motion must be served on the plaintiff or plaintiff’s attorney,
whose name and address are:
If you fail to respond, judgment by default will be entered against you for the relief demanded in the complaint.
You also must file your answer or motion with the court.
CLERK OF COURT
Date:
Signature of Clerk or Deputy Clerk
Case 0:19-cv-62625-RS Document 1-2 Entered on FLSD Docket 10/22/2019 Page 1 of 1
Site is broken everywhere, and who still uses WWW.?
Sad site, bad representation in my opinion, does not reflect what the company is trying to do in my opinion.
I think they used a kid from school, very poorly done.
(I mean the sections at top of HOME etc??? lol, is this 2004?)
Merck's (MRK) Keytruda Gets FDA Approval for Liver Cancer
https://finance.yahoo.com/news/merck-apos-mrk-keytruda-gets-144402737.html
Merck & Co., Inc. MRK announced that the FDA has granted approval to a supplemental new drug application (sBLA) looking to expand the label of its PD-L1 inhibitor, Keytruda.
Keytruda received approval for this filing, on an accelerated basis, for the treatment of advanced hepatocellular carcinoma (HCC), the most common type of liver cancer in patients, previously treated with Bayer/Amgen’s AMGN Nexavar (sorafenib). Continued approval for the indication will depend on confirmation of the clinical benefit in confirmatory studies.
The sBLA filing was based on data from the phase II KEYNOTE-224 study. The outcomes data from the study demonstrated that treatment with Keytruda monotherapy led to an overall response rate (ORR) of 17% in patients with advanced HCC. The data also showed a 1% complete response rate and a 16% partial response rate as a result of treatment with Keytruda.
So far this year, Merck’s shares have outperformed the industry. Merck’s shares have risen 33% in the period compared with 8.3% increase for the industry.
View photos
Keytruda is a key contributor to Merck’s sales.In a very short span of time, Keytruda has become Merck’s largest product. It is already approved for use in 12 indications across eight different tumor types in the United States.
The treatment generated sales of $1.89 billion in the third quarter, up 13% sequentially and 80% year over year. Sales were driven by the launch of new indications globally. Keytruda sales are gaining, particularly from strong momentum in the first-line lung cancer indication. In fact, Keytruda is the only anti-PD-1 approved in the first-line setting for certain lung cancer patients both as a monotherapy as well as a combination therapy.
The Keytruda development program is also progressing well and the drug is being studied for more than 30 types of cancer in more than 850 studies, including more than 400 combination studies. Merck is collaborating with several companies including Amgen, Incyte INCY, Glaxo GSK and Pfizer separately for the evaluation of Keytruda in combination with other regimens.
Keytruda is being studied in late-stage studies for breast, colorectal, esophageal, gastric, head and neck, hepatocellular, nasopharyngeal, renal and small-cell lung cancers.This year, Merck announced positive data from several late-stage studies on Keytruda for further line extensions.
Several regulatory decisions for new indications in the United States as well as in Europe are pending in late 2018/2019, which if approved can further boost sales. A key FDA approval last monthwas the label expansion of Keytruda as a first-line treatment for metastatic squamous non-small cell lung cancer (NSCLC) – a difficult-to-treat lung cancer patient population - based on data from the phase 3 KEYNOTE-407 study.
Though Keytruda had its share of side effects and suffered some major pipeline setbacks, particularly in 2017, it is probably one of the most successful PD-1 and PD-L1 inhibitors in the market now.
News Today! Dividends!
https://finance.yahoo.com/news/generex-biotechnology-corporation-shareholder-alert-130000285.html
Generex Announces Acquisition and Prospective Stock Dividend
Generex Biotechnology Corporation (www.generex.com) (GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) is pleased to announce that the Company has closed the first tranche of a purchase of the going concern assets of a business providing (i) certain specialty pharmacy services and products, (ii) surgical products and services, (iii) diagnostic testing for screening human blood, urine and/or saliva samples for the presence of narcotics, medications, alcohol and other drugs and substances, (iv) durable medical equipment services, and (v) similar ancillary healthcare services, and the provision of management services for the foregoing businesses. In the past 12 months, the purchased assets generated in excess of $66 Million in unaudited revenues through product sales and the provision of services.
Furthermore, in the same transaction, Generex has committed to closing on the acquisition of additional operating assets within the next 30 days that will significantly enhance revenue and establish a platform for growth that is projected to become a lucrative enterprise through expansion from the three states currently served to an additional 23 states targeted in the expansion plan.
It is the Company’s expectation that the acquisition will in due course allow the Company to meet the initial listing requirements for an up-list of its common stock to trading on the Nasdaq Capital Market.
With the restructuring of the Company over the past 19 months and the new platform for growth established through these acquisitions, Generex plans to issue a 20-for-1 stock dividend to shareholders of record; the record date, payment date, and further details of the planned stock dividend will be announced in due course.
Generex management will host an investor conference call in the wake of the additional asset purchase closing to provide shareholders with further details in respect of these acquisitions and the Company’s go-forward plans. Details of the closing of the first acquisition and the terms of the follow-up additional acquisition will be made public in a Form 8-K Current Report to be filed with the Securities and Exchange Commission on Tuesday, October 9, 2018.
Generex President & Chief Executive Officer Joseph Moscato stated, “Over the course of the last two years, our executive management team at Generex has worked diligently to unlock and enhance the value in our Company. Through hard work and a partnership approach, we have identified and acquired a highly successful operating platform with an experienced and successful management team that generates substantial revenues and profits. These acquisitions will drive our development and growth efforts as we execute on our go-forward plans to build a new paradigm for end-to-end treatment and services solutions, placing the doctor/patient relationship at the center of healthcare. With an emphasis on technology, systems, and training of our personnel, we will ensure full compliance with all state and federal regulations, as we provide streamlined and integrated services for patients, physicians, and healthcare systems. We are excited about our future and look forward to providing additional details to our shareholders.”
In the transactions described in this press release, Brooks, Houghton & Company, Inc. acted as the Company’s M&A advisor, and Eckert Semans Cherin & Mellott, LLC served as counsel to the Company.
Cautionary Note Regarding Forward-Looking Statements
This release and oral statements made from time to time by Generex representatives in respect of the same subject matter may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements can be identified by introductory words such as "expects," "plan," "believes," "will," "achieve," "anticipate," "would," "should," "subject to" or words of similar meaning, and by the fact that they do not relate strictly to historical or current facts. Forward-looking statements frequently are used in discussing potential product applications, potential collaborations, product development activities, clinical studies, regulatory submissions and approvals, and similar operating matters. Many factors may cause actual results to differ from forward-looking statements, including inaccurate assumptions and a broad variety of risks and uncertainties, some of which are known and others of which are not. Known risks and uncertainties include those identified from time to time in the reports filed by Generex with the Securities and Exchange Commission, which should be considered together with any forward-looking statement. No forward-looking statement is a guarantee of future results or events, and one should avoid placing undue reliance on such statements. Generex undertakes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise. Generex claims the protection of the safe harbor for forward-looking statements that is contained in the Private Securities Litigation Reform Act.
View source version on businesswire.com: https://www.businesswire.com/news/home/20181004005325/en/
8k Today, Hmmm
Someone knows something. This is very interesting
https://ih.advfn.com/p.php?pid=nmona&article=77828369
Great Article!
Interesting did not know that. Thank you for the info.
Great news, I think the reason I like this company above the rest is the news is very deliberate. Is not just news for news sake. I am holding to the 20's, I have about 40,000 shares at around 4.75 average.
Here we go!
I have a call in to them to see if they can give us any insight.
Agree...We just need some news, this can be MUCH BIGGER then CANN
Company Website
http://www.mountainhighac.com/
This is going to $35!!!
If CANN can do it, so can these guys!
https://www.facebook.com/ClassifiedRide/likes
All from Vietnam?
Ok
http://www.otcmarkets.com/stock/SMAA/financials#
So when was the last time they reported financials? This thing SUCKS, is a horrible promotion. I expect some bad things about to come around...save that money
David Wojcik left the company some time ago, otherwise nice job
CapRock initiates research on PGSI assigns buy rating of $1.50!
Got a promo today
Dear Subscribers,
Exciting news in the Oil And Gas world today coming out of Caprock Risk Management by the super energy analyst Chris Jarvis. We found this small press clip and are looking for the entire report to bring to you asap. Everything we have been saying is on target. Looks like he is being conservative in attaching a price but its still almost a nice double from today's price of $.86. Read the snapshot below:
PGSI's Well Positioned to Have a Breakout Year
- We are initiating coverage on Pegasi Energy Resources Corporation with a STRONG BUY rating and with a 12-month price target of $1.50.
- We derived our $1.50 12-month price target by applying a 6.2x multiple to our Next Twelve Months (NTM) EPS estimate of $0.24. Currently, PGSI's shares trade at 3.5x multiple to our forward earnings estimate, a 65% discount to the company's peer group average multiple of 10.2x.
- We estimate that PGSI will become cash flow positive near the middle of the calendar year 2012 generating revenues of $10.957 million and EPS of $0.09 for the 2012 Calendar year.
- For calendar year 2013 (CY21013), we estimate that PGSI's EPS will rise 241% from $0.09 in 2012 to $0.30 in 2013.
- We are confident in our investment thesis that a strong management team with geological experience and expertise in the Rodessa field and ability to accumulate and consolidate acreage will drive and maximize shareholder wealth.
Chris Jarvis
Caprock Risk Management, LLC
From awesomepennypicks.com
Nice Video and News!
http://finance.yahoo.com/news/lithium-exploration-releases-video-ultrasonic-123000688.html
SCOTTSDALE, Ariz., May 2, 2012 /PRNewswire/ -- Lithium Exploration Group (LEXG.OB) (LEXG.OB) is pleased to release a video of its Ultrasonic Generator. The video shows the Ultrasonic Generator in operation, provides discussion about the technology application, and explains testing program goals. The video can be viewed at www.lithiumexplorationgroup.com.
About Us
Lithium Exploration Group is a US based exploration and development company focused on the acquisition and development potential of lithium brines and other precious metals that demonstrate high probability for near-term production. Currently the company is focused on its Western Canada property. Lithium Exploration Group is a fully reporting company traded on the OTCBB under the symbol LEXG. Website: www.lithiumexplorationgroup.com. Lithium Exploration Group is also now on Facebook, LinkedIn and Twitter @LEXG_OTCBB.
Safe Harbor Statement
This news release contains "forward-looking statements". Statements in this press release that are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future, including but not limited to the completion, testing, transportation, and final installation of the unit.
Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with mineral exploration and difficulties associated with obtaining financing on acceptable terms. We are not in control of lithium prices and these could vary to make development uneconomic. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our most recent annual report for our last fiscal year, our quarterly reports, and other periodic reports filed from time-to-time with the Securities and Exchange Commission.
Contact Info
Shanon Chilson
480-641-4790
info@lithiumexplorationgroup.com
Spoke to Shanon Chilson today. I asked her when she though the generator tests would be complete.
She said they hope next week, is all going great, and we will be amazed by the video out next week of the machine in action.
Great girl, very nice, I am thinking nest week will be exciting. He number was at the bottom of the PR by the way.
News looks good, been a good week, Barchart has it a strong buy, This baby may run to 2 bucks...Im in!
I have to agree, I think the new financials will be huge to seeing the picture.
Also, The press releases haven't really given us anything to sink our teeth into.
http://www.marketwire.com/press-release/sma-alliance-launches-new-platform-issues-shareholder-updates-on-corporate-activity-pinksheets-smaa-1633428.htm
March 19, 2012 16:32 ET
SMA Alliance Launches New Platform and Issues Shareholder Updates on Corporate Activity
NASHVILLE, TN--(Marketwire - Mar 19, 2012) - SMA Alliance, Inc. (www.smaalliance.com) (PINKSHEETS: SMAA) is pleased to announce the full launch of an additional platform developed by Mr. Timothy Stephens, CEO of SMA Alliance. This new platform allows dealers to take advantage of the customer generation abilities of SMA's current software without the monthly flat rate fee. Increase in dealer participation is already being realized by the company and the new platform makes the software affordable to smaller dealers that do not have large advertising budgets. "By going to this sales model, we feel we have increased our client market dramatically and SMA Alliance feels they can easily double their sales this year. As the product develops, dealers will also have the ability to manage their own inventory with user friendly software," stated Mr. Stephens.
Currently, continuation of progress is in full motion as Q1 nears the end. Moving into Q2, SMA Alliance is positioned well within the market to exceed estimated yearend earnings. In addition, former CEO and current Chairman Anthony Baker is diligently acquiring new verticals for revenue growth for SMA Alliance. As previously reported, SMA has an exclusive agreement with International Gold Exploration (IGE). This agreement allows SMA and IGE to secure rights to gold leases internationally. IGE is currently looking at additional joint ventures that could be materialized in the near future. More information on SMA's developments with IGE will be released as progress continues.
SMA is also excited to report the development of ibarlive. "This is one of our most anticipated launches ever. Management of this new development is being structured so that there will be NO conflicts with existing business operations. All of the new developments bring additional value and revenue to SMA Alliance as well as building stronger shareholder confidence," stated Mr. Baker.
Safe Harbor Statement:
This news release includes forward-looking statements pertaining to future anticipated projected plans, performance and developments, intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. Any statements on this news release that are not statements of historical fact should be considered forward-looking statements. These forward-looking statements generally can be identified by phrases such as "believes," "expects," "anticipates," "foresees," "forecasts," "estimates," "intends," or other words or phrases of similar import. Similarly, statements in this news release that describe the Company's business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.
Contact Information
Contact:
SMA ALLIANCE, INC.
Investor Relations
1.888.330.6623
http://www.prlog.org/11824745-sma-alliance-launches-countdown-to-the-largest-development-in-the-history-of-the-company.html
FOR IMMEDIATE RELEASE
PRLog (Press Release) - Mar 15, 2012 -
Nashville, TN – SMA Alliance, inc. is extremely proud to announce that a countdown timer has been launched for an explosive new program. The new program is a development of SMA Alliance and is spearheaded by former CEO, Anthony Baker. Please visit www.ibarlive.com to the countdown until the exact time of the launch.
The launch time and date were strategically chosen for the complete integration of infrastructure and technology. Since the initiation of the website and the digital timer, SMA has seen an enormous amount of enthusiasm, speculation and anticipation. SMA is thrilled about the impact this new development will have on the shareholder and the public in general.
“Moving into the second quarter of 2012, SMA Alliance is on track with the goals we have set for our organization. New developments are unfolding which will bring in additional revenue. More importantly though, SMA Alliance is still advancing within the automotive sector by signing dealerships and new contractual agreements are being negotiated,” stated Mr. Timothy Stephens, CEO of SMA Alliance, Inc.
Safe Harbor Statement:
This news release includes forward-looking statements pertaining to future anticipated projected plans, performance and developments, intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. Any statements on this news release that are not statements of historical fact should be considered forward-looking statements. These forward-looking statements generally can be identified by phrases such as "believes," "expects," "anticipates," "foresees," "forecasts," "estimates," "intends," or other words or phrases of similar import. Similarly, statements in this news release that describe the Company's business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.
Contact:
Timothy Stephens / CEO
1.888.330.6623
Please note ROCKETTRADER is on the bans list.
Great Point!
For some reason, They removed it and re uploaded it, therefore changing the link...too bad , I bet view count would have been much higher!
yeah finally getting good news...Seems who ever did this release did it the real way.
The last one
http://www.prlog.org/11800063-international-gold-extraction-corporation-details-on-public-statements-regarding-agreemen.html
Wasn't even on a real wire.
A lot of times, the bottom of these release is info about the company. The site I could find was
http://www.igeglobal.com
Says nothing really, SMA give us info on this partner!
I tired the contact us form, but it is broken....
I would just like them to stick to Auto industry though...Some posters here have seen the magic these guys do, and seemed to be doing well..
Maybe there is more than meets the eye, but is my concern.
NEW JUSTIN VIDEO!
Really? The new PR guy for SMA is attacking investors?
Let us wait for the financials to be released and see the real story...
I am stuck on this and another stock a business acquaintance told me about..Both not doing well anymore...
I hope it bumps back to a .10 soon.
As their new public relations guy, this is your reply?
Wow
Does this company even really exist? How long have they been in business, and what state are they incorporated in? When I see a website that is under 90 days old, and a claim of hundreds of millions of gold, excuse me for asking questions.
AGREE!
Well...
Registrar: DOMAIN
Domain Name: IGEGLOBAL.COM
Created on: 30-JAN-12
Expires on: 31-JAN-13
Last Updated on: 30-JAN-12
And the Facebook fanpage was created by
Sarah Mercedes
So I am curious, as it seems to be they own IGE Global...
Then some may note the StockMerlin links on Tony's wall
I went to this link there
http://stockmerlin.com/profile/AnthonyBaker?xg_source=profiles_memberList
Seems they have more interest in hedonism then their own company. In face if you go to the link she posts here:
"Please copy the link and lets get some members to chat and get some great people over here...http://hedonism2.ning.com
Status posted by Anthony & Sarah Baker Jun 30, 2011 "
I get redirected to the stock merlin site..Makes me think the site is a "copy and paste" of their old Hedonism site? Do they own Stockmerlin.com also?
Registrar: DOMAIN
Domain Name: STOCKMERLIN.COM
Created on: 06-DEC-11
Expires on: 06-DEC-12
Last Updated on: 06-DEC-11
Come say I am a basher Rocketman, and I am happy you have the shareholders list, etc. I am not close to Tampa, so I think I will pass on the offer.
I have posted facts only, and if they are seen as negative, oh well. Fact is, none have ever been proven false, I challenge you on this.
Seriously, as an objective investor, in a PINK, you have to understand my concerns...
Address, them and I will be ok, call me a basher, makes me want to dig more.
Good luck to you either way..
P.S. I am now looking into http://signupnewsletter.com
Appreciate any comments you may want to make before I publish what I found.
PRESS RELEASE
http://www.prlog.org/11798021-sma-alliance-signs-exclusive-mining-agreement-with-international-gold-extraction-corporation.html
SMA Alliance Signs Exclusive Mining Agreement with International Gold Extraction Corporation
$340,000,000 in Gold Reserves Verified by Geological and 43-101 Technical Report
FOR IMMEDIATE RELEASE
PRLog (Press Release) - Feb 13, 2012 -
NASHVILLE, TN - SMA Alliance (Pinksheets: SMAA.PK) is pleased to announce that an exclusive contract has been signed with International Gold Extraction Corporation (IGE). An estimated $340 million dollars in Gold reserves are at stake as the two companies’ partner up in an aggressive mining campaign. Full geological reports combined with 43-101 technical reports are available by visiting www.signupnewsletter.com As further developments occur, statements will be issued to be public accordingly.
International Gold Extraction Corp. (IGE) is teaming up with the proven lead generation technology offered by SMA Alliance, inc in a effort to drive international attention to the website. As mentioned in previous public statements, this allows SMA Alliance an introduction into the finance vertical. Continued gains in market share as well as shareholder equity are the driving force of SMA Alliance, Inc.
Safe Harbor Statement:
This news release includes forward-looking statements pertaining to future anticipated projected plans, performance and developments, intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. Any statements on this news release that are not statements of historical fact should be considered forward-looking statements. These forward-looking statements generally can be identified by phrases such as "believes," "expects," "anticipates," "foresees," "forecasts," "estimates," "intends," or other words or phrases of similar import. Similarly, statements in this news release that describe the Company's business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.
Contact:
Timothy Stephens / CEO
949-891-7279
SMA is now into GOLD mining? So Tony Baker steps down, so he can run a GOLD mine and an auto marketing company?
WOW
http://signupnewsletter.com/
I am going to dig now, something is fishy.
Let's hope there is, looking forward to financials.